{"version":"1.0","provider_name":"Voisins de l'UE","provider_url":"https:\/\/www.eumedbridge.eu\/fr\/","author_name":"Nidhal Battikh","author_url":"https:\/\/www.eumedbridge.eu\/fr\/author\/nidhal_admin\/","title":"Lettre d\u2019information d\u2019INVESTMED \u2013 Num\u00e9ro 1 \u2013 Mars 2021 - Voisins de l'UE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XiOFlAYSmC\"><a href=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/lettre-dinformation-dinvestmed-numero-1-mars-2021\/\">Lettre d\u2019information d\u2019INVESTMED \u2013 Num\u00e9ro 1 \u2013 Mars 2021<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/lettre-dinformation-dinvestmed-numero-1-mars-2021\/embed\/#?secret=XiOFlAYSmC\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Lettre d\u2019information d\u2019INVESTMED \u2013 Num\u00e9ro 1 \u2013 Mars 2021\u00a0\u00bb &#8212; Voisins de l&#039;UE\" data-secret=\"XiOFlAYSmC\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.eumedbridge.eu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2022\/03\/Capture_20-1.jpg","thumbnail_width":421,"thumbnail_height":602,"description":"Le premier num\u00e9ro de la newsletter du projet INVESTMED pr\u00e9sente des informations concernant le lancement du projet, la premi\u00e8re conf\u00e9rence de presse en ligne et les activit\u00e9s de la premi\u00e8re phase du projet. Les lecteurs peuvent \u00e9galement en apprendre davantage sur les objectifs et les partenaires du projet. INVESTMED (Innovative Sustainable Start-Ups for the Mediterranean) [&hellip;]"}